Health Condition 1: E70-E88- Metabolic disorders
Conditions
Interventions
Intervention1: Habb e Zarawand: 5 Habb of 700mg each orally OD at night for 8 weeks
Control Intervention1: Atorvastatin: 10mg orally OD at night for 8 weeks
Sponsors
National Institute Of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of Hyperlipidemia confirmed with laboratory test and found with the values of plasma total cholesterol less than 200mg/dl,LDL Cholesterol less than 190mg/dl, Triglycerides less than 499 mg/dl. 2. Known cases of Hyperlipidemia with disease history of less than 5 years. 3. Known cases of type II Diabetes Mellitus, Hypothyroidism, Normotensives (with or without medication), Obesity (BMI less than 30, Stage-I -Asian Indian Population). 4. Age 20 to 60yrs and all gender.
Exclusion criteria
Exclusion criteria: 1. History of Coronary Artery Disease, severe systemic and metabolic diseases. 2. Known cases on use of corticosteroids and immunosuppressive agents 3. Known cases of alcoholism and smoking. 4. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in plasma levels of LDL Cholesterol, Total Cholesterol, TrigylceridesTimepoint: 0th day and 8th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in plasma levels of triglyceridesTimepoint: 0th day and 8th week | — |
Countries
India
Contacts
Public ContactDr Musfira Anjum S
National Institute Of Unani Medicine
Outcome results
None listed